TrianglePUBLICATIONS · 36808285
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Neuro Oncol
- Publication date
- 2023 Aug 3
- First author
- Dunkel IJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Dunkel IJ
- type
- Author
- name
- Doz F
- type
- Author
- name
- Foreman NK
- type
- Author
- name
- Hargrave D
- type
- Author
- name
- Lassaletta A
- type
- Author
- name
- André N
- type
- Author
- name
- Hansford JR
- type
- Author
- name
- Hassall T
- type
- Author
- name
- Eyrich M
- type
- Author
- name
- Gururangan S
- type
- Author
- name
- Bartels U
- type
- Author
- name
- Gajjar A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dunkel IJ
- type
- Author
- name
- Doz F
- type
- Author
- name
- Foreman NK
- type
- Author
- name
- Hargrave D
- type
- Author
- name
- Lassaletta A
- type
- Author
- name
- André N
- type
- Author
- name
- Hansford JR
- type
- Author
- name
- Hassall T
- type
- Author
- name
- Eyrich M
- type
- Author
- name
- Gururangan S
- type
- Author
- name
- Bartels U
- type
- Author
- name
- Gajjar A
- type
- Author
- bibliography ids
- nci-bib-e9f90213a40da8e895fa1124
- book metadata
- content sha256
- f229656f051a9426c3c2df12e1dd9c6fa442942c1973790d001a83536777b509
- document type
- citation
- dois
- 10.1093/neuonc/noad031
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36808285
- immutable id
- pubmed:36808285@f229656f051a9426c3c2df12e1dd9c6fa442942c1973790d001a83536777b509
- journal
- abbreviation
- Neuro Oncol
- issn electronic
- 1523-5866
- issn print
- 1522-8517
- issue
- 8
- name
- Neuro-oncology
- nlm unique id
- 100887420
- pages
- 1530-1545
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36808285
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- 49f2064fc94ac1c50c1f34c38150c787898b2ede6e2533f4a87312e05f94e82c
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Aug 3
- precision
- day
- year
- 2023
- publication types
- Clinical Trial, Phase II
- Clinical Trial, Phase I
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908.
Preserved source evidence · Not medical advice